Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

NCT02319837 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1068

Enrollment

INDUSTRY

Sponsor class

Conditions

Hormone Sensitive Prostate Cancer
Prostate Cancer
Cancer of the Prostate

Interventions

DRUG: Enzalutamide
DRUG: Placebo (No longer applicable in Open Label study period)
DRUG: Leuprolide Open Label

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]